Found vs BreezeMeds: Personalized Plans vs Discreet Pricing
Found vs BreezeMeds: If you want a biology-first, medically supervised program with insurance support, Found stands out; if you need straightforward per-medication pricing and discreet home delivery, BreezeMeds may fit. Early verdict: Found emphasizes personalized biology-based plans and insurance handling starting at as low as $39, while BreezeMeds presents per-medication starting prices (semaglutide injection from $199/mo) and discreet shipping.
Explore Found biology-first plans
How Found and BreezeMeds differ on pricing and insurance
Found promotes affordable monthly plans with “get started for as low as $39” and states most insurance is now accepted, including handling insurance paperwork and programs for eligible Medicare Part D members. BreezeMeds displays per-product starting prices such as semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options starting at $399, and notes pricing and eligibility are subject to the live offer. The providers show two distinct approaches: Found highlights membership pricing and insurance assistance, while BreezeMeds lists explicit starting prices per medication.
Medication options and regulatory notes
Both providers offer GLP-1 options, but the specifics differ. Found lists tirzepatide and semaglutide and notes compounded semaglutide and tirzepatide are available in some cases, with the important qualifier that compounded GLP-1s are not FDA approved or evaluated for safety or efficacy and are not available in all states. BreezeMeds lists injectable and oral semaglutide and tirzepatide options, and cautions that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. Both providers state treatment is available only when a licensed clinician determines it is medically appropriate.
Personalization and care model
Found emphasizes a biology-first, personalized medically supervised weight loss program that evaluates hormones, blood sugar regulation, sleep, and behavior to build individualized plans. BreezeMeds describes a clinician-reviewed online treatment with a personalized treatment plan, but the captured evidence emphasizes intake and clinician review rather than the broader biology-first framing. In practice, Found positions personalization around metabolic biology, while BreezeMeds emphasizes clinician review and a personalized plan without the same biology-first language.
Compare Found personalized plans
Shipping, delivery and membership features
BreezeMeds highlights discreet home delivery and ongoing support, with multiple starting-price points shown and some pricing elements not fully itemized in the captured evidence. Found focuses on membership plans, flexible pricing, cancel anytime language, and notes programs like the Medicare GLP-1 Bridge Program for eligible Part D members, plus insurance paperwork handling. Found also presents offer details and one-time checkout discounts in the captured offer language. Shipping and state availability details for both providers require confirmation based on the live offer and clinician review.
Direct comparison table
| Criteria | Found | BreezeMeds |
|---|---|---|
| Starting price | Get started for as low as $39 (membership) | Semaglutide injection from $199/mo; other meds from $299 to $399 |
| Insurance | Most insurance now accepted; Found handles paperwork; Medicare Bridge program noted | Pricing and eligibility subject to live offer; insurance acceptance not confirmed in captured evidence |
| Medication formats | Tirzepatide, semaglutide; compounded options noted with regulatory qualifier | Injectable and oral semaglutide and tirzepatide; starting prices shown for each |
| Personalization | Biology-first personalized medically supervised programs | Clinician-reviewed online treatment with personalized plan |
| Shipping and delivery | Membership and med kit options referenced; shipping details require confirmation | Discreet home delivery emphasized |
| Regulatory note | Compounded GLP-1s are not FDA approved or evaluated for safety or efficacy | Medication-specific approval status must be confirmed; compounded products require confirmation |
What the evidence does not show
The captured source rows do not provide full details on state availability, complete fee schedules, refund policies in full, specific clinical outcomes, or detailed enrollment and renewal terms for either provider. Where policies or pricing require live-offer confirmation, the providers note eligibility and clinician review apply.
Bottom line and how to choose
Found vs BreezeMeds boils down to priorities. Found is focused on a biology-first, holistic membership model with affordable entry pricing and insurance handling, and it explicitly calls out compounded GLP-1 regulatory limits. BreezeMeds presents per-medication starting prices, both injectable and oral GLP-1 options, and discreet home delivery, with pricing and eligibility tied to the live offer.
Choose Found if…
You want a biology-first, personalized, medically supervised program that emphasizes insurance handling and membership pricing with a stated entry point as low as $39 and you accept that compounded GLP-1s are not FDA approved and may not be available in all states.
Choose BreezeMeds if…
You prefer explicit per-medication starting prices, want injectable and oral GLP-1 options presented with discreet home delivery, and will confirm pricing, eligibility, state availability and approval status through the live offer and clinician review.
Primary keyword: Found vs BreezeMeds
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
